Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation

Journal of Clinical Investigation

Volumn 117, Issue 3, 2007, Pages 703-711

  Khoury, Joseph ^a   Ibla, Juan C ^a   Neish, Andrew S ^b   Colgan, Sean P ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A2B RECEPTOR; ADENOSINE RECEPTOR; COP9 SIGNALOSOME; COP9 SIGNALOSOME SUBUNIT 5; CULLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HYPOXIA; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL;

ADAPTATION, PHYSIOLOGICAL; ADENOSINE; ANIMALS; ANOXIA; CELL CYCLE PROTEINS; CULLIN PROTEINS; HELA CELLS; HUMANS; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG; MICE; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDE HYDROLASES; PNEUMONIA; RNA, SMALL INTERFERING;

EID: 33847339352     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI30049     Document Type: Article

References (51)

1. Haddad, J.J. 2003. Science review: redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: role for hypoxiainducible factor-1alpha. Crit. Care. 7:47-54.
2. Kokura, S., Yoshida, N., and Yoshikawa, T. 2002. Anoxia/reoxygenation- induced leukocyte-endothelial cell interactions. Free Radic. Biol. Med. 33:427-432.
3. Saadi, S., Wrenshall, L.E., and Platt, J.L. 2003. Regional manifestations and control of the immune system. FASEB J. 16:849-856.
4. Zhang, S.X., Miller, J.J., Gozal, D., and Wang, Y. 2004. Whole-body hypoxic preconditioning protects mice against acute hypoxia by improving lung function. J. Appl. Physiol. 96:392-397.
5. Cope, G.A., and Deshaies, R.J. 2003. COP9 signalosome: a multifunctional regulator of SCF and other cullin-based ubiquitin ligases. Cell. 114:663-671.
6. Cardozo, T., and Pagano, M. 2004. The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell Biol. 5:739-751.
7. Ohta, A., and Sitkovsky, M. 2001. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature. 414:916-920.
8. Fishman, P., Bar-Yehuda, S., Madi, L., and Cohn, I. 2002. A3 adenosine receptor as a target for cancer therapy. Anticancer Drugs. 13:437-443.
9. Li, S., Huang, S., and Peng, S.B. 2005. Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression. Int. J. Oncol. 27:1329-1339.
10. Linden, J. 2001. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol. 41:775-787.
11. Merighi, S., et al. 2003. A glance at adenosine receptors: novel target for antitumor therapy. Pharmacol. Ther. 100:31-48.
12. Sitkovsky, M., and Lukashev, D. 2005. Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat. Rev. Immunol. 5:712-721.
13. Decking, U.K., Schlieper, G., Kroll, K., and Schrader, J. 1997. Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release. Circ. Res. 81:154-164.
14. 2B receptors. J. Exp. Med. 198:783-796.
15. Synnestvedt, K., et al. 2002. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 (HIF-1) mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110:993-1002. doi:10.1172/JCI200215337.
16. Cummins, E.P., and Taylor, C.T. 2005. Hypoxia-responsive transcription factors. Pflugers Arch. 450:363-371.
17. Algarte, M., Kwon, H., Genin, P., and Hiscott, J. 1999. Identification by in vivo genomic footprinting of a transcriptional switch containing NF-kappaB and Sp1 that regulates the IkappaBalpha promoter. Mol. Cell. Biol. 19:6140-6153.
18. Baxter, G.F. 2002. Role of adenosine in delayed preconditioning of myocardium. Cardiovasc. Res. 55:483-494.
19. Mubagwa, K., and Flameng, W. 2001. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc. Res. 52:25-39.
20. de Jonge, R., Bradamante, S., and de Jong, J.W. 1998. Cardioprotection by ischemic preconditioning. Role of adenosine and glycogen. Adv. Exp. Med. Biol. 431:279-282.
21. Hasko, G., and Cronstein, B.N. 2004. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25:33-39.
22. Linden, J. 2005. Adenosine in tissue protection and tissue regeneration. Mol. Pharmacol. 67:1385-1387.
23. Sitkovsky, M.V., et al. 2004. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 22:657-682.
24. Chen, Z.J. 2005. Ubiquitin signalling in the NF-kappaB pathway. Nat. Cell Biol. 7:758-765.
25. Luo, J.L., Kamata, H., and Karin, M. 2005. IKK/NF-κB signaling: balancing life and death - a new approach to cancer therapy. J. Clin. Invest. 115:2625-2632. doi:10.1172/JCI26322.
26. Collier-Hyams, L.S., Sloane, V., Batten, B.C., and Neish, A.S. 2005. Cutting edge: bacterial modulation of epithelial signaling via changes in neddylation of cullin-1. J. Immunol. 175:4194-4198.
27. Mikus, P., and Zundel, W. 2005. COPing with hypoxia. Semin. Cell Dev. Biol. 16:462-473.
28. Thompson, L.F., et al. 2004. Crucial role for ecto-5′-nucleotidase (CD73) in vascular leak during hypoxia. J. Exp. Med. 200:1395- 1405.
29. Whayne, T.F., Jr., and Severinghaus, J.W. 1968. Experimental hypoxic pulmonary edema in the rat. J. Appl. Physiol. 25:729-732.
30. Nathan, C. 2002. Points of control in inflammation. Nature. 420:846-852.
31. Bartsch, P., Mairbaurl, H., Maggiorini, M., and Swenson, E.R. 2005. Physiological aspects of high-altitude pulmonary edema. J. Appl. Physiol. 98:1101-1110.
32. Basnyat, B., and Murdoch, D.R. 2003. High-altitude illness. Lancet. 361:1967-1974.
33. Barnes, P.J., and Karin, M. 1997. Nuclear factor-κB - a pivitol transcription factor in chronic inflammatory disease. N. Engl. J. Med. 336:1066-1071.
34. Wojcik, C., and Di Napoli, M. 2004. Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy. Stroke. 35:1506-1518.
35. Chen, Z., et al. 1995. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev. 9:1586-1597.
36. Amir, R.E., Iwai, K., and Ciechanover, A. 2002. The NEDD8 pathway is essential for SCF(beta-TrCP)-mediated ubiquitination and processing of the NF-kappa B precursor p105. J. Biol. Chem. 277:23253-23259.
37. Jarrar, D., et al. 2002. Alveolar macrophage activation after trauma-hemorrhage and sepsis is dependent on NF-kappaB and MAPK/ERK mechanisms. Am. J. Physiol. Lung Cell. Mol. Physiol. 283:L799-L805.
38. Shenkar, R., et al. 1996. Hemorrhage activates NF-kappa B in murine lung mononuclear cells in vivo. Am. J. Physiol. 270:L729-L735.
39. Majumdar, S., and Aggarwal, B.B. 2003. Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types. Oncogene. 22:1206-1218.
40. Read, M.A., et al. 2000. Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha. Mol. Cell. Biol. 20:2326-2333.
41. El Eter, E., Hagar, H.H., Al-Tuwaijiri, A., and Arafa, M. 2005. Nuclear factor-kappaB inhibition by pyrrolidinedithiocarbamate attenuates gastric ischemia-reperfusion injury in rats. Can. J. Physiol. Pharmacol. 83:483-492.
42. Frantz, S., et al. 2006. Absence of NF-kappaB subunit p50 improves heart failure after myocardial infarction. FASEB J. 20:1918-1920.
43. Eltzschig, H.K., et al. 2004. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood. 104:3986-3992.
44. Kong, T., Westerman, K.A., Faigle, M., Eltzschig, H.K., and Colgan, S.P. 2006. HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J. 20:2242-2250.
45. Yang, D., et al. 2006. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J. Clin. Invest. 116:1913-1923. doi:10.1172/JCI27933.
46. Sun, C.X., et al. 2006. Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J. Clin. Invest. 116:2173-2182. doi:10.1172/JCI27303.
47. Parry, G., and Estelle, M. 2004. Regulation of cullin-based ubiquitin ligases by the Nedd8/RUB ubiquitin-like proteins. Semin. Cell Dev. Biol. 15:221-229.
48. Gan-Erdene, T., et al. 2003. Identification and characterization of DEN1, a deneddylase of the ULP family. J. Biol. Chem. 278:28892-28900.
49. Mendoza, H.M., et al. 2003. NEDP1, a highly conserved cysteine protease that deNEDDylates Cullins. J. Biol. Chem. 278:25637-25643.
50. Wu, K., et al. 2003. DEN1 is a dual function protease capable of processing the C terminus of Nedd8 and deconjugating hyper-neddylated CUL1. J. Biol. Chem. 278:28882-28891.
51. Ibla, J.C., and Khoury, J. 2006. Methods to assess tissue permeability. Methods Mol. Biol. 341:111-117.